Usefulness of HeberFERON® in patients with basal cell carcinoma

• Main Authors: Natacha López Pupo (Author), Yarien Manganelly Fonseca (Author), María Elena Tablada Robinet (Author), Ana Lucía Jacas Portuondo (Author), Yaimaris Girón Maturell (Author)
• Format: Book
• Published: Centro Provincial de Información de Ciencias Médicas, 2021-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: The basal cell carcinoma is the most frequent epithelial neoplasm, because it constitutes 60-80 % of all the cutaneous cancers.  Objective: To determine the answer to HeberFERON® in patients with basal cell carcinoma.  Methods:  An observational, descriptive and longitudinal study of 9...